DOCA—Salt高血压大鼠模型的一种简易制备方法：DOCA硅胶管皮下埋入法

用外径４ｍｍ,内径２．５０ｍｍ的硅胶管制成长２５ｍｍ,管内填入ＤＯＣＡ１００ｍｇ,管壁钻有１０一１４个直径约３００μｍ微孔的药管,埋入雄性ＳＤ大鼠（１４０±９ｇ）右下腹皮下,摘除一侧肾脏,术后喂１％盐水。埋管后３周即可形成高血压,埋管后８周大鼠的收缩压达２３．３±０．３７ｋＰａ。而ＤＯＣＡ皮下注射组大鼠（１０ｍｇ／周）术后５周形成高血压,术后１３周大鼠的收缩压达２３．３±０．６６ｋＰａ。两组升压曲线回归系数（１．２９５和０．６９２）之间的差异有极显著性意义（Ｐ＜０．００１）。对照鼠的收缩压一直保持在正常水平（１６±０．１６ｋＰａ）。与ＤＯＣＡ皮下注射法相比,皮下埋管法具有两个显著优点：（１）升压速率较快,升压幅度较大;（２）方法简便可靠,重复性好。     

豚鼠腹腔神经节细胞γ－氨基丁酸双相反应的药理学特性

在豚鼠腹腔神经节细胞,γ－氨基丁酸（ＧＡＢＡ）可诱发“去极化－超极化”的双相反应,去极化伴膜电阻减小,超极化伴膜电阻增大,这种反应在低钙高镁液中仍然存在。蝇蕈醇可模拟ＧＡＢＡ双相反应,但在诱发相同强度的去极化反应时,蝇蕈醇产生的超极化弱于ＧＡＢＡ。荷包牡丹碱（１００μｍｏｌ／Ｌ）和印防已毒素（１００—３００μｍｏｌ／Ｌ）能可逆地抑制ＧＡＢＡ诱发的双相反应。Ｂａｃｌｏｆｅｎ对神经节细胞的膜电位无明显影响。结果提示,ＧＡＢＡ双相反应的去极化相由ＧＡＢＡＡ／Ｃｌ－通道受体复合物介导,而超极化相很可能由不同于经典的ＧＡＢＡＡ受体,但其药理学行为又由与之十分相近的另一种ＧＡＢＡ受体介导。     

艾氏剂环氧化酶及细胞色素P－450对小菜蛾抗药性发展的影响

本文对室内长期饲养的小菜蛾（Ｐｌｕｔｅｌｌａ　ｘｙｌｏｓｔｅｌｌａ　Ｌ．）敏感品系和田间采集的抗性种群体内的艾氏剂平氧化酶及细胞色素Ｐ－４５０进行了比较研究。结果证明,艾氏剂环氧化酶在感性和抗性小菜蛾间存在着量及质的差异。抗性种群的艾氏剂环氧化酶的Ｖｍａｘ和Ｋｍ值分别为感性品系的５．４％和６．５倍。抗性种群的细胞色素Ｐ－４５０的含量是感性品系的１．１—１．３倍。艾氏剂环氧化酶在量上及质上的差异及细胞色素Ｐ－４５０含量的提高是导致小菜蛾抗药性发生与发展的重要机制之一。而且质的差异较之量的差异可能起着更为重要的作用．     

Analysis of the frequency of inheritance of transposed Ds elements in Arabidopsis after activation by a CaMV 35S promoter fusion to the Ac transposase gene

The Ac/Ds transposon system of maize shows low activity in Arabidopsis. However, fusion of the CaMV 35S promoter to the transposase gene (35S::TPase) increases the abundance of the single Ac mRNA encoded by Ac and increases the frequency of Ds excision. In the experiments reported here it is examined whether this high excision frequency is associated with efficient re-insertion of the transposon. This was measured by using a Ds that carried a hygromycin resistance gene (HPT) and was inserted within a streptomycin resistance gene (SPT). Excision of Ds therefore gives rise to streptomycin resistance, while hygromycin resistance is associated with the presence of a transposed Ds or with retention of the element at its original location. Self-fertilisation of most individuals heterozygous for Ds and 35S::TPase produced many streptomycin-resistant (strep^r) progeny, but in many of these families a small proportion of strep^r seedlings were also resistant to hygromycin (hyg^r). Nevertheless, 70% of families tested did give rise to at least one strep^r, hyg^r seedling, and over 90% of these individuals carried a transposed Ds. In contrast, the Ac promoter fusion to the transposase gene (Ac::TPase) produced fewer strep^rhyg^r progeny, and only 53% of these carried a transposed Ds. However, a higher proportion of the strep^r seedlings were also hyg^r than after activation by 35S::TPase. We also examined the genotype of strep^r, hyg^r seedlings and demonstrated that after activation by 35S::TPase many of these were homozygous for the transposed Ds, while this did not occur after activation by Ac::TPase. From these and other data we conclude that excisions driven by 35S::TPase usually occur prior to floral development, and that although a low proportion of strep^r progeny plants inherit a transposed Ds, those that do can be efficiently selected with an antibiotic resistance gene contained within the element. Our data have important implications for transposon tagging strategies in transgenic plants and these are discussed.     

A Protein Extracted from Mouse Sperm That Plays an Important Role in Fertilization

ＡＰｒｏｔｅｉｎＥｘｔｒａｃｔｅｄｆｒｏｍＭｏｕｓｅＳｐｅｒｍＴｈａｔＰｌａｙｓａｎＩｍｐｏｒｔａｎｔＲｏｌｅｉｎＦｅｒｔｉｌｉｚａｔｉｏｎＺＨＵＡＮＧＤａ－ｚｈｏｎｇ;（庄大中）,ＺＨＡＮＧＴｉａｎ－ｙｉｎ（张天荫）,ＣＨＥＮＤａ－ｙｕａｎ;（陈大...     

Coordinated mRNA and Protein Expression of Human LAMP-1 in Induction of Melanogenesis After UV-B Exposure and Co-Transfection of Human Tyrosinase and TRP-1 cDNAs

In order to better understand the cascade of melanogenic events in melanocytes, this report has introduced our two recent approaches for the expression of melanogenesis/or melanosome-associated genes and encoded proteins in melanocytes (melanoma cells) after repeated exposure to UV -B and after cotransfection of two human genes, i.e., tyrosinase and tyrosinase-related protein-1 (TRP-1). Repeated exposure of UV B (2.5–5.0 mJ/cm²) caused not only upregulation of tyrosinase and TRP-1 genes but also coordinated increase in the gene and protein synthesis expression of Lamp-1 (lysosome-associated membrane protein-1). When COS-7 kidney cells and amelanotic melanoma (C32 and SKMEL-24) and melanotic melanoma (G361 and SK-MEL-23) cells were exposed to cotransfection of human tyrosinase and TRP-1 cDNAs, there was also an increased expression of Lamp-1 mRNA and protein along with tyrosinase activation and new melanin synthesis. Importantly, single transfectants of human tyrosinase cDNA revealed marked cellular degeneration, whereas this degeneration was not seen in single transfectants of TRP-1 cDNA or cotransfectants of human tyrosinase and TRP-1 cDNAs, indicating that TRP-1 prevented, along with Lamp-1, programmed death of melanocytes after transfection of tyrosinase gene. The coordinated expression of TRP-1 and Lamp-1 was further confirmed by antisense oligodeoxynucleotide hybridization experiment against Lamp-1 gene, showing the decreased expression of TRP-1 as identified by three different types of anti-TRP-1 monoclonal antibodies. We propose therefore that human tyrosinase and TRP-l, when activated or expressed together, will coordinate to upregulate the mRNA expression and protein synthesis of Lamp-1. The Lamp-1 molecules will, in turn, cover the inner surface of melanosomal membrane, together with TRP-1 molecules, thus protecting the melanosomal membrane from toxic melanin intermediates generated during melanogenesis in the presence of active tyrosinase. In contrast, the expression of other lysosome-related proteins, e.g., β-galactosidase and CD63 is not stimulated in new melanogenesis.     

A stage—specific protein factor binding to a CACCC motif in both human β—globin gene promoter and 5‘—HS2 region

The DNaseI hypersensitive site 2 (HS2) of human β-globin locus control region(LCR) is required for the high level expression of human β-globin genes.In the present study,a stage-specific protein factor (LPF-β) was identified in the nuclear extract prepared from mouse fetal liver at d 18 of gestation,which could bind to the HS2 region of human β-globin LCR.We also found that the shift band of LPF-β factor could be competed by human β-globin promoter.However,it couldn‘t be competed by human ε-globin promoter or by human ^Aγ-globin promoter.Furthermore,our data demonstrated that the binding-sequence of LPF-β factor is 5‘CACACCCTA 3‘,which is located at the HS2 region of β-LCR(from-10845 to-10853 bp)and human β-globin promoter(from-92 to -84 bp).We speculated that these regions containing the CACCC box in both the human β-globin promoter and HS2 might function as stage selector elements in the regulation of human β-globin switching and the LPF-β factor might be a stage-specific protein factor involved in the regulation of human β-globin gene expression.     

Chromosome 14 and late-onset familial Alzheimer disease (FAD)

Familial Alzheimer disease (FAD) is genetically heterogeneous. Two loci responsible for early-onset FAD have been identified: the amyloid precursor protein gene on chromosome 21 and the as-yet-unidentified locus on chromosome 14. The genetics of late-onset FAD is unresolved. Maximum-likelihood, affected-pedigree-member (APM), and sib-pair analyses were used, in 49 families with a mean age at onset ≥60 years, to determine whether the chromosome 14 locus is responsible for late-onset FAD. The markers used were D14S53, D14S43, and D14S52. The LOD score method was used to test for linkage of late-onset FAD to the chromosome 14 markers, under three different models: age-dependent penetrance, an affected-only analysis, and age-dependent penetrance with allowance for possible age-dependent sporadic cases. No evidence for linkage was obtained under any of these conditions for the late-onset kindreds, and strong evidence against linkage (LOD score ≤ –2.0) to this region was obtained. Heterogeneity tests of the LOD score results for the combined group of families (early onset, Volga Germans, and late onset) favored the hypothesis of linkage to chromosome 14 with genetic heterogeneity. The positive results are primarily from early-onset families. APM analysis gave significant evidence for linkage of D14S43 and D14S52 to FAD in early-onset kindreds (P < .02). No evidence for linkage was found for the entire late-onset family group. Significant evidence for linkage to D14S52, however, was found for a subgroup of families of intermediate age at onset (mean age at onset ≥60 years and <70 years). These results indicate that the chromosome 14 locus is not responsible for Alzheimer disease in most late-onset FAD kindreds but could play a role in a subset of these kindreds.